34 studies found for:
" June 25, 2008":" July 25, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults
|
||||
| 2 | Completed |
Lovastatin: Immunomodulatory Value Evaluation
|
||||
| 3 |
Completed
Has Results |
Safety and Efficacy Study of Switching From Epzicom to Truvada
|
||||
| 4 | Terminated |
Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
|
||||
| 5 | Active, not recruiting |
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
|
||||
| 6 | Completed |
Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand
|
||||
| 7 | Active, not recruiting |
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
|
||||
| 8 | Active, not recruiting |
Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients
|
||||
| 9 |
Completed
Has Results |
Single DermaVir Immunization in HIV-1 Infected Patients on HAART
|
||||
| 10 | Recruiting |
Intervention for (Those) Recently Informed of Seropositive Status (IRISS)
|
||||
| 11 | Completed |
Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy
|
||||
| 12 | Active, not recruiting |
Healthy Activities for Prize Incentives
|
||||
| 13 | Completed |
Effectiveness of a Community-Level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-Risk Populations
|
||||
| 14 | Active, not recruiting |
Study of Raltegravir Versus Nucleotide Reverse Transcriptase Inhibitors (NRTIs) as a Backbone in HIV-Infected Subjects Switched From a Stable Boosted Protease Inhibitor (PI) Regimen
|
||||
| 15 | Active, not recruiting |
Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection
|
||||
| 16 | Unknown † |
Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
|
||||
| 17 | Completed |
Family Centered Advanced Care Planning for Adolescents With HIV/AIDS and Their Families
|
||||
| 18 |
Completed
Has Results |
Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function
|
||||
| 19 | Completed |
Impact of an HPV Vaccine in HIV-Infected Young Women
|
||||
| 20 | Terminated |
Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy
|
† Indicates status has not been verified in more than two years
